CILP2 and pancreatic neoplasm: Furthermore, the IHC analysis showed that the decreased expression of CILP2 led to decreased levels of Ki-67, N-cadherin, and vimentin, as well as increased levels of E-cadherin in the orthotopic pancreatic cancer model.